Skip to main content
. 2022 Mar 10;7:78. doi: 10.1038/s41392-022-00925-z

Fig. 9.

Fig. 9

Cell signaling pathways participant in regulating pathological processes and phenotypes after MI (Created with BioRender.com). PI3K/Akt phosphoinositide-3 kinase/protein kinase B, TGF-β/SMADs transforming growth factor-β/SMADs, Wnt/β-catenin wingless/β-catenin, NLRP3/caspase-1 nucleotide-binding domain, leucine-rich-repeat family, pyrin-domain-containing 3/caspase-1, TLR4/MyD88/NF-κB toll-like receptor 4/MyD88/Nuclear factor-κB, Nrf2/HO-1 nuclear factor erythroid derived 2-related factor 2/heme oxygenase-1, MAPK mitogen-activated protein kinase, JAK/STAT Janus kinase/signal transducer and activator of transcription, Hippo/YAP Hippo/Yes-associated protein